EP2682114
Milnacipran for the long-term treatment of fibromyalgia syndrome
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
27.9.2006EP published:
4.11.2020EP application number:
13187396.0
EPO information:
European Patent Register
Max expiry date:
26.9.2026
Title:
Milnacipran for the long-term treatment of fibromyalgia syndrome
Timeline
Today
27.9.2006EP application
4.11.2020EP Publication
Owner
Name:
Cypress Bioscience, Inc.Address:
4350 Executive Drive, Suite 325, San Diego, CA 92121, US
Inventor
Name:
Rao, Srinivas, G.Address:
Encinitas, CA California 92024, US
Name:
Gendreau, MichaelAddress:
Poway, CA California 92064, US
Name:
Kranzler, Jay, D.Address:
La Jolla, CA California 92037, US
Priority
Number:
721722 PDate:
28.9.2005Country:
US
Classification
Categories:
A61K 31/165, A61K 31/197, A61K 45/06, A61P 19/02, A61P 25/04